Carregant...

DDIS-03. HARNESSING siRNA NANOMEDICINE FOR THERAPEUTIC GENE SILENCING IN GLIOBLASTOMA

GBM is the most common primary brain tumor in adults, with a very poor prognosis. Despite tremendous efforts to develop new drugs, the treatment of GBM remains a great challenge. The use of nanoparticles (NPs) has emerged as a potential strategy for diagnosis and treatment of tumors, GBM especially....

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neuro Oncol
Autors principals: Gutkin, Anna, Peer, Dan, Cohen, Zvi
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2017
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5692115/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.239
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!